Cointime

Uygulamayı indirmek için QR kodu tarayın
iOS & Android

Alnylam Pharmaceuticals

company
Funding Round
Post-IPO Equity
Money Raised
$ 800M
Propotion
-
Post Valuation
-

Current Round Investors

Investor Name Invest Money Lead Investor Propotion
Regeneron - Yes - Detail

Historical Financing

Announced Date Round Money Raised Investors
Jul 7, 2003 Private Equity(PE) $ 24.60M Merck,ARCH Venture Partners Detail
Mar 28, 2011 Post-IPO Equity $ 10M Takeda Detail